Cancer Research UK logo.
SearchDonate
  • Search

A study to learn more about how drugs that switch off oestrogen affect breast cancer cells (FemarA)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 3

Details

This study looked at tissue samples to compare the effects of drugs called anastrozole (Arimidex) and letrozole (Femara) on breast cancer cells.

Recruitment start: 1 June 2002

Recruitment end: 17 December 2010

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor JM Dixon

Supported by

Experimental Cancer Medicine Centre (ECMC)

Novartis

Last reviewed: 05 Dec 2013

CRUK internal database number: 4373

Help and support